Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03070925 · ClinicalTrials.gov registry record
Prospective PuraPly™ AM Case Series Study
A clinical trial of Pressure Ulcers and Venous Ulcers, sponsored by Organogenesis.
- Completed
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT03070925 is a study of Pressure Ulcers and Venous Ulcers that has completed, run by Organogenesis. The registered enrollment target is 43 participants, below the 225-participant average among 5 other Pressure Ulcers trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03070925, a study of Pressure Ulcers and Venous Ulcers, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The PuraPly AM case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylene biguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental intervention is involved.
Conditions Studied
Interventions
- DEVICE PuraPly™ Antimicrobial Wound Matrix
Study Locations (1)
New York
- Northwell Health, Inc - Lake Success
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03070925
The ClinicalTrials.gov registry entry for NCT03070925 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 225-participant average among 5 other Pressure Ulcers trials with a reported enrollment target (81% lower). The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Pressure Ulcers appearing as the primary indexed condition, and to 1 intervention - of which PuraPly™ Antimicrobial Wound Matrix is the first listed.
NCT03070925 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03070925 about?
NCT03070925 is a clinical study titled "Prospective PuraPly™ AM Case Series Study". The PuraPly AM case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylene biguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental intervention is involved.
What is the current status of trial NCT03070925?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2016-11. Estimated completion is 2017-05.
What conditions does trial NCT03070925 study?
This clinical trial studies the following conditions: Pressure Ulcers, Venous Ulcers, Diabetic Ulcers, Surgical Wounds, Trauma Wounds.
What interventions are being tested in trial NCT03070925?
The interventions under investigation include: PuraPly™ Antimicrobial Wound Matrix (DEVICE).
Who is sponsoring clinical trial NCT03070925?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03070925 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pressure Ulcers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
RECRUITING · NA
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
Wound Management for Sacral Pressure Ulcers With Necrotic Tissue
COMPLETED · Phase 4
-
Pressure Ulcer Prevention: Turning for Ulcer Reduction
COMPLETED · Phase 3
-
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.